Literature DB >> 16873700

Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy.

Aleksey V Matveyenko1, Johannes D Veldhuis, Peter C Butler.   

Abstract

Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) often coexist and as such represent a potent risk factor for subsequent development of type 2 diabetes. beta-Cell mass is approximately 50% deficient in IFG and approximately 65% deficient in type 2 diabetes. To establish the effect of a approximately 50% deficit in beta-cell mass on carbohydrate metabolism, we performed a approximately 50% partial pancreatectomy versus sham surgery in 14 dogs. Insulin secretion was quantified from insulin concentrations measured in the portal vein at 1-min sampling intervals under basal conditions, after a 30-g oral glucose, and during a hyperglycemic clamp. Insulin sensitivity was measured by a hyperinsulinemic-euglycemic clamp combined with isotope dilution. Partial pancreatectomy resulted in IFG and IGT. After partial pancreatectomy both basal and glucose-stimulated insulin secretion were decreased through the mechanism of a selective approximately 50 and approximately 80% deficit in insulin pulse mass, respectively (P < 0.05). These defects in insulin secretion were partially offset by decreased hepatic insulin clearance (P < 0.05). Partial pancreatectomy also caused a approximately 40% decrease in insulin-stimulated glucose disposal (P < 0.05), insulin sensitivity after partial pancreatectomy being related to insulin pulse amplitude (r = 0.9, P < 0.01). We conclude that a approximately 50% deficit in beta-cell mass can recapitulate the alterations in glucose-mediated insulin secretion and insulin action in humans with IFG and IGT. These data support a mechanistic role of a deficit in beta-cell mass in the evolution of IFG/IGT and subsequently type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873700     DOI: 10.2337/db06-0345

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Aging does not reduce heat shock protein 70 in the absence of chronic insulin resistance.

Authors:  Kylie Kavanagh; Ashley T Wylie; Tara J Chavanne; Matthew J Jorgensen; V Saroja Voruganti; Anthony G Comuzzie; Jay R Kaplan; Charles E McCall; Stephen B Kritchevsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-08       Impact factor: 6.053

Review 2.  Pancreatic stem cells: from possible to probable.

Authors:  Fang-Xu Jiang; Grant Morahan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

3.  Arginine is preferred to glucagon for stimulation testing of β-cell function.

Authors:  R Paul Robertson; Ralph H Raymond; Douglas S Lee; Roberto A Calle; Atalanta Ghosh; Peter J Savage; Sudha S Shankar; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

4.  Assessment of pulsatile insulin secretion derived from peripheral plasma C-peptide concentrations by nonparametric stochastic deconvolution.

Authors:  Marcello C Laurenti; Adrian Vella; Ron T Varghese; James C Andrews; Anu Sharma; Nana Esi Kittah; Robert A Rizza; Aleksey Matveyenko; Giuseppe De Nicolao; Claudio Cobelli; Chiara Dalla Man
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-26       Impact factor: 4.310

Review 5.  Genetics of type 2 diabetes.

Authors:  Galina Smushkin; Adrian Vella
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

6.  Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.

Authors:  Erik Ingelsson; Claudia Langenberg; Marie-France Hivert; Inga Prokopenko; Valeriya Lyssenko; Josée Dupuis; Reedik Mägi; Stephen Sharp; Anne U Jackson; Themistocles L Assimes; Peter Shrader; Joshua W Knowles; Björn Zethelius; Fahim A Abbasi; Richard N Bergman; Antje Bergmann; Christian Berne; Michael Boehnke; Lori L Bonnycastle; Stefan R Bornstein; Thomas A Buchanan; Suzannah J Bumpstead; Yvonne Böttcher; Peter Chines; Francis S Collins; Cyrus C Cooper; Elaine M Dennison; Michael R Erdos; Ele Ferrannini; Caroline S Fox; Jürgen Graessler; Ke Hao; Bo Isomaa; Karen A Jameson; Peter Kovacs; Johanna Kuusisto; Markku Laakso; Claes Ladenvall; Karen L Mohlke; Mario A Morken; Narisu Narisu; David M Nathan; Laura Pascoe; Felicity Payne; John R Petrie; Avan A Sayer; Peter E H Schwarz; Laura J Scott; Heather M Stringham; Michael Stumvoll; Amy J Swift; Ann-Christine Syvänen; Tiinamaija Tuomi; Jaakko Tuomilehto; Anke Tönjes; Timo T Valle; Gordon H Williams; Lars Lind; Inês Barroso; Thomas Quertermous; Mark Walker; Nicholas J Wareham; James B Meigs; Mark I McCarthy; Leif Groop; Richard M Watanabe; Jose C Florez
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

7.  Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Authors:  V Delghingaro-Augusto; C J Nolan; D Gupta; T L Jetton; M G Latour; M Peshavaria; S R Murthy Madiraju; E Joly; M-L Peyot; M Prentki; J Leahy
Journal:  Diabetologia       Date:  2009-03-18       Impact factor: 10.122

8.  Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.

Authors:  Aleksey V Matveyenko; Johannes D Veldhuis; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

9.  Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose.

Authors:  Xia Li; Yu-Hsiang Shu; Anny H Xiang; Enrique Trigo; Johanna Kuusisto; Jaana Hartiala; Amy J Swift; Miwa Kawakubo; Heather M Stringham; Lori L Bonnycastle; Jean M Lawrence; Markku Laakso; Hooman Allayee; Thomas A Buchanan; Richard M Watanabe
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

10.  Defining and characterizing the progression of type 2 diabetes.

Authors:  Vivian A Fonseca
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.